26732 Federal Register / Vol. 60, No. 96 / Thursday, May 18, 1995 / Notices

9:45 a.m. to 11:00 a.m. on June 9 for

program and poster presentations.

Attendance by the public will be limited

to space available.

In accordance with the provisions set

forth in sec. 552b(c)(6), Title 5, U.S.C.

and sec. 10(d) of Pub. L. 92–463, the

meeting will be closed to the public

from 6:00 p.m. until recess on June 7

and from 12:30 p.m. until adjournment

on June 9 for the review, discussion,

and evaluation of individual programs

and projects conducted by the NIDR,

including consideration of personnel

qualifications and performance, the

competence of individual investigators,

and similar items, the disclosure of

which would constitute a clearly

unwarranted invasion of personal

privacy.

Mr. Brent Jaquet, Director, Office of

Planning, Evaluation, and

Communications, NIDR, NIH, Building

31, Room 2C34, Bethesda, Maryland

20892 (telephone: (301) 496–6705) will

provide summary of the meeting, roster

of committee members and substantive

program information. Individuals who

plan to attend and need special

assistance, such as sign language

interpretation or other reasonable

accommodations, should contact the

Executive Secretary listed above in

advance of the meeting.

Dated: May 11, 1995.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 95–12192 Filed 5–17–95; 8:45 am]

BILLING CODE 4140–01–M

Prospective Grant of Exclusive

License: Polysaccharide-Protein

Conjugates

AGENCY: National Institutes of Health,

Public Health Service, DHHS.

ACTION: Notice.

SUMMARY: This notice is in accordance

with 15 U.S.C. 209(c)(1) and 37 CFR

404.7(a)(1)(i) that the National Institutes

of Health (NIH), Department of Health

and Human Services, is contemplating

the grant of an exclusive world-wide

license to practice the invention

embodied in U.S. Patent Number

5,204,098 entitled ‘‘PolysaccharideProtein Conjugates’’ and related foreign

patent applications to Connaught

Laboratories, Inc., of Swiftwater,

Pennsylvania. The patent rights in this

invention have been assigned to the

United States of America.

The prospective exclusive license will

be royalty-bearing and will comply with

the terms and conditions of 35 U.S.C.

209 and 37 CFR 404.7. It is anticipated

that this license will be limited to the

field of typhoid vaccines and typhoid

Vi-protein conjugates for the prevention

of typhoid fever in humans. This

prospective exclusive license may be

granted unless within 60 days from the

date of this published notice, NIH

receives written evidence and argument

that establishes that the grant of the

license would not be consistent with the

requirements of 35 U.S.C. 209 and 37

CFR 404.7.

The patent describes conjugates of

bacterial capsular polysaccharides and

carrier proteins, and methods of

synthesis, wherein the polysaccharide

and protein are linked through a thio

derivative of a carboxyl group found on

the polysaccharide. The conjugates are

useful as vaccines for prevention of

disease caused by infection by the

bacterial species from which the

capsular polysaccharide is derived.

ADDRESSES: Requests for a copy of this

patent, inquiries, comments and other

materials relating to the contemplated

license should be directed to: Robert

Benson, Patent Advisor, Office of

Technology Transfer, National Institutes

of Health, 6011 Executive Blvd., Box 13,

Rockville, MD 20852. Telephone: (301)

496–7056, X267; Facsimile: (301) 402–

0220. Applications for a license filed in

response to this notice will be treated as

objections to the grant of the

contemplated license. Only written

comments and/or applications for a

license which are received by NIH on or

before July 17, 1995, will be considered.

Dated: May 5, 1995.

Barbara M. McGarey,

Deputy Director, Office of Technology

Transfer.

[FR Doc. 95–12193 Filed 5–17–95; 8:45 am]

BILLING CODE 4140–01–P

DEPARTMENT OF HOUSING AND

URBAN DEVELOPMENT

Office of the Assistant Secretary for

Community Planning and

Development

[Docket No. N–95–3888; FR–3886–N–04]

Homeownership of Single Family

Homes Program (HOPE 3); Notice of

Fund Availability: Notice of Extension

of Application Deadline for Applicants

in Oklahoma

AGENCY: Office of the Assistant

Secretary for Community Planning and

Development, HUD.

ACTION: Notice of further extension of

deadline.

SUMMARY: This notice provides a further

extension of the application submission

deadline for the HOPE 3 applicants

affected by the destruction of HUD’s

Office in Oklahoma City, Oklahoma. An

extension of this deadline was already

published on May 9, 1995, but because

of a typographical error, the new

deadline was misstated. In addition,

because of the destruction of documents

due to the Oklahoma City explosion,

any applicant that has already

submitted an application under the

HOPE 3 NOFA to HUD’s Office in

Oklahoma City should resubmit a copy

of its application to the Fort Worth

Office, as provided in this notice.

DATES: The application deadline for

applicants from Oklahoma will be May

19, 1995, 4:30 Central Time.

FOR FURTHER INFORMATION CONTACT: For

applicants in Oklahoma, contact Will

Williamson, HOPE 3 Coordinator,

phone (817) 885–5887. For general

information about this notice, contact

Salvatore Sclafani, Program Analyst,

Office of Community Planning and

Development, Department of Housing

and Urban Development, Room 7208,

451 Seventh Street, SW., Washington,

DC 20410, telephone (202) 708–1283; or

(202) 708–2565 (TDD). (These telephone

numbers are not toll-free.)

SUPPLEMENTARY INFORMATION: Because of

the destruction of the HUD Office in

Oklahoma City, Oklahoma, on April 19,

1995, the Department published a notice

in the Federal Register (60 FR 24646,

May 9, 1995) to extend the deadline for

the submission of applications for

certain programs, including the HOPE 3

Program. The Notice extended the

application deadline for HOPE 3

applicants within the State of Oklahoma

from April 25, 1995, to May 8, 1995.

Because of a typographical error, the

fact that some documents may be

unaccounted for due to the destruction

of documents in the Oklahoma City

explosion, and the time required for

applicants to resubmit copies of HOPE

3 applications to the Fort Worth Office,

the Department has decided to provide

an additional extension of time—to May

19, 1995—for HOPE 3 applicants in the

State of Oklahoma. Any applicant under

the HOPE 3 NOFA that has already

submitted an application to the

Oklahoma City office is directed to

resubmit its application to HUD’s Fort

Worth Office, as indicated below in this

notice. Photocopies of all of the

documentation and materials as

originally submitted to the Oklahoma

City Office will be acceptable, as long as

the applicant also provides proof of

submission (e.g., postal or Federal

Express receipt). Completed

applications may not be submitted by

fax.